Clinical impact of borderline and undiagnosed diabetes mellitus in patients with coronary artery disease

被引：27

作者：

Tenenbaum, A ^{[1
]}

Metro, M

Fisman, EZ

Boyko, V

Mandelzweig, L

Reicher-Reiss, H

Graff, E

Brunner, D

Behar, S

机构：

[1] Chaim Sheba Med Ctr, Cardiac Rehabil Inst, IL-52621 Tel Hashomer, Israel

[2] Neufeld Cardiac Res Inst, Bezafibrate Infarct Prevent Study Coordinating Ct, Tel Aviv, Israel

[3] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2000年 / 86卷 / 12期

关键词：

D O I：

10.1016/S0002-9149(00)01244-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The present study was aimed to evaluate the prevalence and prognostic significance of unrecognized and newly defined borderline diabetes (with fasting blood sugar 126 to 139 mg/dl) by the American Diabetes Association criteria in coronary patients over a 7.7year follow-up. Both undiagnosed and newly diagnosed borderline diabetes were associated with an unfavorable metabolic profile. The mortality of the borderline diabetics tended to be higher than in their nondiabetic counterparts, but this tendency did not reach statistical significance. A significant excess in long-term mortality was observed among the undiagnosed diabetes group.

引用

页码：1363 / +

页数：6

共 16 条

[1]

[Anonymous], 1999, National Heart, Lung, and Blood Institute (NHILBI): The DASH Diet

[2]

Behar S, 1995, J Cardiovasc Risk, V2, P241, DOI 10.1097/00043798-199506000-00010

[3] Fibrinogen is a predictor of mortality in coronary heart disease patients [J].

Benderly, M ;

Graff, E ;

ReicherReiss, H ;

Behar, S ;

Brunner, D ;

Goldbourt, U .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (03) :351-356

[4]

Borch-Johnsen K, 1998, BMJ-BRIT MED J, V317, P371

[5] Rapid rise in the incidence of type 2 diabetes from 1987 to 1996 - Results from the San Antonio Heart Study [J].

Burke, JP ;

Williams, K ;

Gaskill, SP ;

Hazuda, HP ;

Haffner, SM ;

Stern, MP .

ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (13) :1450-1456

[6]

Gavin JR, 1997, DIABETES CARE, V20, P1183

[7] RATIONALE AND DESIGN OF A SECONDARY PREVENTION TRIAL OF INCREASING SERUM HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND REDUCING TRIGLYCERIDES IN PATIENTS WITH CLINICALLY MANIFEST ATHEROSCLEROTIC HEART-DISEASE (THE BEZAFIBRATE INFARCTION PREVENTION TRIAL) [J].

GOLDBOURT, U ;

BEHAR, S ;

REICHERREISS, H ;

AGMON, J ;

KAPLINSKY, E ;

GRAFF, E ;

KISHON, Y ;

CASPI, A ;

WEISBORT, J ;

MANDELZWEIG, L ;

ABINADER, E ;

AHARON, L ;

BRAUN, S ;

DAVID, D ;

FLICH, M ;

FRIEDMAN, Y ;

KRISTAL, N ;

LEIL, N ;

MARKIEWICZ, W ;

MARMOR, A ;

PALANT, A ;

PELLED, B ;

RABINOWITZ, B ;

REISIN, L ;

ROGUIN, N ;

ROSENFELD, T ;

SCHLESINGER, Z ;

SCLAROVSKY, S ;

SHERF, L ;

TZIVONI, D ;

ZAHAVI, I ;

ZION, M ;

BRUNNER, D ;

FRIDENSOHN, A ;

JAFARI, J ;

OSTFELD, B ;

ROCHFLEISH, S ;

SCHNEIDER, H ;

KHALID, S ;

NARINSKY, R ;

ROTZAK, R ;

VITRAI, J ;

PELLED, B ;

PARDU, J ;

LANIADO, S ;

ESHCHAR, Y ;

ARDITI, A ;

BOTWIN, S ;

ROGUIN, N ;

YAHALOM, M .

AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (11) :909-915

[8] Diabetes and cardiovascular disease - A statement for healthcare professionals from the American Heart Association [J].

Grundy, SM ;

Benjamin, IJ ;

Burke, GL ;

Chait, A ;

Eckel, RH ;

Howard, BV ;

Mitch, W ;

Smith, SC ;

Sowers, JR .

CIRCULATION, 1999, 100 (10) :1134-1146

[9] Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults - The Third National Health and Nutrition Examination Survey, 1988-1994 [J].

Harris, MI ;

Flegal, KM ;

Cowie, CC ;

Eberhardt, MS ;

Goldstein, DE ;

Little, RR ;

Wiedmeyer, HM ;

Byrd-Holt, DD .

DIABETES CARE, 1998, 21 (04) :518-524

[10] Comparison of the results between two diagnostic criteria by ADA and WHO among subjects with FPG 5.6-7.8 mmol/l in Kin-Hu and Kin-Chen, Kinmen, 1991-94 [J].

Li, CL ;

Tsai, ST ;

Chou, PS .

DIABETES RESEARCH AND CLINICAL PRACTICE, 1999, 45 (01) :51-59

← 1 2 →